Verónica Arroyave is the Director of Corporate Responsibility and AbbVie Foundation for AbbVie. In that capacity, she advances AbbVie’s commitment as a socially responsible company supporting global philanthropic programs and alliance building.
With the AbbVie Foundation, she has expanded philanthropic initiatives in Latin America in strategic priority areas such as neglected tropical diseases, pediatric oncology, and non-communicable diseases. Veronica has worked in academic, corporate, government and non-profit management roles for over fifteen years catalyzing global health partnerships across sectors championing philanthropic opportunities to strengthen communities worldwide.
Prior to joining the AbbVie Foundation, Veronica was a Global Health Fellow for the Partnership for Quality Medical Donations (PQMD) where she conducted field research in Haiti post-2010’s earthquake. She has advised for organizations such as Johnson & Johnson, Schering-Plough, Wyeth, Project HOPE, Medical Teams International, and Carilion Foundation. With MAP International, she led a team responsible for field implementation and global medical logistics across 90+ countries. Veronica also worked with USAID’s MEASURE Evaluation project supporting the prevention and evaluation of HIV/AIDS programs in Latin America and Africa. Veronica has a Bachelors of Science from Our Lady of Holy Cross College, a Masters from Tulane University’s School Public Health & Tropical Medicine and a Ph.D. from Virginia Tech’s School of Public and International Affairs.
Dr. Bruno Battistini President, CEO and Scientific Director, NEW BRUNSWICK HEALTH RESEARCH FOUNDATION
Dr. Bruce Bloom is President and Chief Science Officer of Cures Within Reach, a nonprofit corporation saving lives since 2005 by repurposing human approved drugs and devices to quickly deliver safe and affordable treatments and cures for diseases that have no currently effective therapy. Cures Within Reach uses CureAccelerator™, the only global online repurposing research collaboration platform, to bring together clinicians, researchers, funders and industry to create and conduct pilot clinical trials that quickly drive more treatments to more patients. Dr. Bloom is an Ashoka Fellow, recognized as a social entrepreneur for his system-changing solutions to one of the world’s most urgent social problems, finding new treatments for unsolved diseases. Dr. Bloom is the Patient Advisory Board Chair for the Institute for Translational Medicine; on the Science Advisory Boards of Rediscovery Life Sciences, the GARROD AKU Consortium, the Dr. Ralph and Marian Falk Medical Research Trust Awards Programs, the Findacure Social Impact Bond Initiative, and Healx, LTD; Chair of the Governance Committee of the Kendall College Charitable Trust; a member of the Board of Councilors of Midwestern University; and a member of the editorial board of ASSAY and Drug Development Technologies. Dr. Bloom hosts the Clinician’s Roundtable on ReachMD.com, and is a facilitator for Pathways to Successful Living.
Brian Fisher has more than 20 years of experience in the pharmaceutical industry from sales to managed care and including marketing and product launch. Before working with The Sturge-Weber Foundation, Mr. Fisher was Managed Care National Accounts Manager for Schering-Plough Pharmaceuticals; Western Regional Sales Director for Draxis Health of Canada; and Sales, Marketing Rotations and Institutional Sales Trainer with Bayer Pharmaceuticals. Mr. Fisher’s strengths lay in patient advocacy after experiences in cross-functional pharmaceutical roles as he develops partnerships between industry and patient advocacy organizations. Mr. Fisher regularly lobbies in Washington, D.C., drawing attention to patient insurance support, translational research science, and rare diseases ultimately benefiting multisystem disease states.
Elias Jackson, Ph.D. CEO, VYRIPHARM BIOPHARMACEUTICAL
Dr. Elias Jackson is the co-founder, President of Research and Development and Director of Scientific Public Relations for Vyripharm Biopharmaceuticals, a precision medicine biotechnology firm that develops drugs to target cancer, PTSD, drug addiction and other metabolic diseases. He was previously a professor and research faculty member at the Cardiovascular Research Center at the Yale University School of Medicine, and is a graduate of The University of Texas Medical Branch at Galveston.
Thoma Kikis Chief Marketing Officer, KANNALIFE
Darshan Kulkarni FDA Regulatory and Compliance Attorney, THE KULKARNI LAW FIRM
Kimberly Lincoln Manufacturing Scientist, ROCHE
Dean Petkanas Chief Medical Officer, KANNALIFE SCIENCES
Barbara Read Vice President of Sales and Marketing, LIFESCRIPT
Mark Reichman EVP, Client Services Director, GUIDEMARK HEALTH
Cannabis Patient Advocate
Jeremy Unruh General Counsel and Chief Compliance Officer, PHARMACANN LLC